open access

Vol 3, No 3 (2010)
Conference report / Report
Published online: 2010-10-05
Get Citation

Hemafereza lecznicza

Aleksandra Rosiek
Journal of Transfusion Medicine 2010;3(3):92-98.

open access

Vol 3, No 3 (2010)
SPRAWOZDANIA
Published online: 2010-10-05

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Hemafereza lecznicza

Journal

Journal of Transfusion Medicine

Issue

Vol 3, No 3 (2010)

Article type

Conference report / Report

Pages

92-98

Published online

2010-10-05

Bibliographic record

Journal of Transfusion Medicine 2010;3(3):92-98.

Authors

Aleksandra Rosiek

References (25)
  1. Łętowska M. Medyczne zasady pobierania krwi, oddzielania jej składników i wydawania, obowiązujące w jednostkach organizacyjnych publicznej służby krwi. Instytut Hematologii i Transfuzjologii, Warszawa 2006: (supl. 2010).
  2. Guide to the preparation, use and quality assurance of blood components, European Directorate for the Quality of Medicines & HealthCare (EDQM), recommendation No. R (95) 15, 16 th ed, 2011.
  3. Carden B, McEvoy P, Reed B, et al. A roundtable discussion: from thoughts on supply and demand to what keeps us up at night. Transfusion. 2011; 51(7 Pt 2): 1635–1642.
  4. Bove LL, Bednall T, Masser B, et al. Understanding the plasmapheresis donor in a voluntary, nonremunerated environment. Transfusion. 2011; 51(11): 2411–2424.
  5. Koster J, Hassall OW. Attitudes towards blood donation and transfusion in Bamenda, Republic of Cameroon. Transfus Med. 2011; 21(5): 301–307.
  6. Ayyoubi MT, Konstenius T, McCullough JC, et al. Status of blood banking and the blood supply in Afghanistan. Transfusion. 2010; 50(3): 566–574.
  7. Joshi SR, Shah Al-Bulushi SN, Ashraf T. Development of blood transfusion service in Sultanate of Oman. Asian J Transfus Sci. 2010; 4(1): 34–40.
  8. Chapman JF, Hyam C, Hick R. Blood inventory management. Vox Sang. 2004; 87 Suppl 2: 143–145.
  9. Simon TL. Where have all the donors gone? A personal reflection on the crisis in America's volunteer blood program. Transfusion. 2003; 43(2): 273–279.
  10. Greinacher A, Fendrich K, Hoffmann W. Demographic Changes: The Impact for Safe Blood Supply. Transfus Med Hemother. 2010; 37(3): 141–148.
  11. Główny Urząd Statystyczny, Komitet Redakcyjny. Rocznik demograficzny 2010.
  12. Rosiek A, Rzymkiewicz L, Owczarska K, et al. Charakterystyka osób oddających krew honorowo w czasie ekip wyjazdowych organizowanych przez Instytut Hematologii i Transfuzjologii — analiza danych demograficznych, motywacji i wybranych badań. Acta Haemat Pol. 2005; 36: 197–206.
  13. Maniatis A. Criteria for clinical transfusion practice. In: Rouger P, Hossenlopp C. ed. Blood transfusion in Europe. The White Book 2005. Elsevier, Paris 2005: 205–212.
  14. Hillyer KL. The blood donor, donation process and technical aspects of blood collection. In: Hillyer KL, Shatz BZ, Zimring JC. ed. Transfusion Medicine and Hemostasis. Clinical and Laboratory Aspects. Elsevier 2009: 25–35.
  15. Riley W, Schwei M, McCullough J. The United States' potential blood donor pool: estimating the prevalence of donor-exclusion factors on the pool of potential donors. Transfusion. 2007; 47(7): 1180–1188.
  16. Kamp C, Heiden M, Henseler O, et al. Management of blood supplies during an influenza pandemic. Transfusion. 2010; 50(1): 231–239.
  17. Rabel PO, Planitzer CB, Farcet MR, et al. Increasing West Nile virus antibody titres in central European plasma donors from 2006 to 2010. Euro Surveill. 2011; 16(10).
  18. Alter HJ, Stramer SL, Dodd RY. Emerging infectious diseases that threaten the blood supply. Semin Hematol. 2007; 44(1): 32–41.
  19. Gorlin J. Blood donor deferrals: biting the hand that feeds us! Transfusion. 2008; 48(12): 2484–2486.
  20. Poppvsky MA. Understanding the donor can correct the nation's blood imbalance. Transfusion. 2006; 46(4): 501–502.
  21. Gilcher RO. It's time to end RBC shortages. Transfusion. 2003; 43(12): 1658–1660.
  22. Schreiber GB, Schlumpf KS, Glynn SA, et al. National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study. Convenience, the bane of our existence, and other barriers to donating. Transfusion. 2006; 46(4): 545–553.
  23. AuBuchon JP. Current status of pathogen inactivation methods. ISBT Science Series. 2010; 5(n1): 125–133.
  24. Gathof BS, Tauszig ME, Picker SM. Pathogen inactivation/reduction of platelet concentrates: turning theory into practice. ISBT Science Series. 2010; 5(n1): 114–119.
  25. Lachert E, Antoniewicz-Papis J. Metody inaktywacji czynników chorobotwórczych w składnikach krwi. Journal of Transfusion Medicine. 2010; 3: 112–119.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Journal of Transfusion Medicine dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl